Lumira Capital
Lumira Ventures, Canada's largest life sciences venture capital firm, invests in healthcare innovators from early-stage to revenue-generating biotech, biotherapeutics, and medical devices. Headquartered in Toronto, Ontario.
In the firm's own words, from its website.
13 additional team members, 19 additional co-investors and affiliates, 8 additional investments, funds and LPs, 7 events, 6 verified contacts (5 professional url, 1 firm phone)
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 2 companiesnew in 12 months
2 new companies in the last 12 months. Took 1 board seat on new Form D filings in 90 days (Navion Neurosciences).
A firm writing cheques this quarter is one a founder can pitch now.
- 1 companyportfolio raising
One portfolio company has new financing on record in 6 months without this firm named on the round; the latest on 10 Jun 2026 ($1.95M sold on Form D).
A portfolio company raising again is a follow-on decision for the firm and a co-investment opening for others.
People to know
View all people- Managing PartnerWhy: Managing partner: runs the firmNo route on file yet
- Managing General PartnerWhy: General partner: carries the investment decisionNo route on file yet
- Managing DirectorWhy: Managing directorNo route on file yet
Relationship network
36 connected entities3 observed rounds1 dated round shown here, 2026
From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.
Some relationships on this record are counted rather than named here. They open with the full profile.
Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.
- Sponsor
- Company
- Fund or vehicle
- Person
›How strength and recency are read
Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.
Darker lines were active in the last 24 months or are current; lighter lines are older or undated.
How am I connected?
Name your firm, a company or a person, and DFX finds the published routes to Lumira Capital: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.
See how you connect to Lumira Capital
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Investing
6 companies on record, 2 new in 12 months
Investments on record
What these amounts mean“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.Acquired, Public, Exited and Active are what the firm’s own portfolio card says, read on the date shown when you hover the chip; they are not deal dates. A company with no chip is one whose card states no outcome: DFX does not assume it is active.| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Corvia Medical, Inc. | portfolio listing | unknown | unknown | unknown | unknown | Sep 30, 2026 | Fact Company website |
| Organiq Media | portfolio listing | unknown | unknown | unknown | unknown | Sep 30, 2026 | Fact Firm website |
| Navion Neurosciences Inc. | board seat | unknown · board | Suman Rao (strongly supported) | unknown | unknown | Sep 22, 2026 | Inference Form D |
Stated thesis versus observed behaviour
- Sectors
- biotech, medtech, media
- Stages
- series a, series b, growth
- Geography
- boston, canada, global
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Team
16 current, 8 departed
Decision makers
- Gerry Brunk · Managing PartnerWhy this person: Managing partner: runs the firm; Named with investment responsibility
- Peter van Der Velden · Managing General PartnerWhy this person: General partner: carries the investment decision; Named with investment responsibility
- Gerald Albert Brunk · Managing DirectorWhy this person: Managing director; Named with investment responsibility
Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.
Investment team
How the team is orderedPartners who lead rounds first (rounds led, then deals attributed, then seniority), then the rest of the investment team, then investor relations, finance and operations. A person named by two sources under two spellings is shown once.- Managing Partner
- Managing General Partner
- Managing Director · 1 deal attributed
2 departed (kept with end dates)
- Brian James Underdown · Managing Director · Jul 1, 2007 to Mar 24, 2016 Inference
- Andrew James Haigh · Senior Associate · Mar 1, 2012 to Mar 27, 2015 Inference
Contacts
1 firm phone, 5 professional url on record, each with its source. Values open with the complete profile.
Funds and LPs
8 vehicles, 0 LPs disclosed
Funds and vehicles
What these amounts meanGAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Lumira Ventures IV (international), L.P. | Fund | 2022 adv first reported | Active deployment | $26.7M Mar 30, 2026 | 13 | unknown | unknown |
| Lumira Ventures IV Holding LP | Fund | 2022 adv first reported | Active deployment | $4.5M Mar 30, 2026 | 8 | unknown | unknown |
| Lumira Capital IV (international), L.P. | Fund | 2018 adv first reported | Harvest | $5.0M Mar 30, 2026 | 4 | unknown | unknown |
Limited partners
Known LPs and allocators
What these amounts and dates areEach commitment is counted once across the pension tape and the allocator graph. A commitment date prints only when the source printed one; otherwise the row carries the report date. A foundation’s 990-PF line is a holding at fair value, never a commitment. Rows without a fund on the venture graph are commitments to this manager.Relationships across DFX
6 co-investors
Co-investors
- 2026-10-011 shared deal · one time
- 2026-09-301 shared deal · one time
- 2026-03-191 shared deal · one time
Evidence and history
12 dated events, 62 observations from 3 sources
Timeline
- Mar 30, 2022Lumira Ventures IV Holding LP first reported on Form ADV by Lumira Capital (Venture Capital Fund), GAV $1,009,000
- Mar 30, 2022Lumira Ventures IV (international), L.P. first reported on Form ADV by Lumira Capital (Venture Capital Fund), GAV $11,303,000
- Jan 1, 2022
- Mar 5, 2018Lumira Capital IV (international), L.P. first reported on Form ADV by Lumira Capital (Venture Capital Fund), GAV $501,000
- Mar 5, 2018Lumira Capital IV GP, L.P. first reported on Form ADV by Lumira Capital (Venture Capital Fund)
Identity and regulatory footprint
Address, phone, Form ADV filing and ownersForm ADV filed Mar 30, 2026 · 8 private fundsShowHide
- Headquarters
- Toronto, Ontario, Canadaadviserinfo.sec.gov
- Office address
- unknownadviserinfo.sec.gov
- Business phone
- unknownadviserinfo.sec.gov
- Website
- LUMIRACAPITAL.COM
- SEC adviser type
- Exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- Private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- Mar 30, 2026
- Private funds reported
- 8 (8 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets, adviser total
- $66.6Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Brunk, Gerald Albert (Limited Partner, Executive), owns 75% or more; Lumira Capital (USA) Inc. (Common Shareholder), owns 75% or more; Rovinski, Benjamin (President), owns 75% or more
Classification history
Classification history
Every classification this record has carried2 on recordShowHide
- Sep 23, 2026Institutional venture firm (probable, 80%)Venture manager, reported GAV $67M across 8 vehicles
- Sep 12, 2026Institutional venture firm (probable, 80%)Venture manager, reported GAV $58M across 8 vehicles
Evidence
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|---|---|---|---|
| SEC exemption claimed | Private fund adviser | Mar 25, 2024 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 30, 2026 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 25, 2024 | Fact | Form ADV |
| First Form ADV filing | 2012-05-14 | Mar 30, 2026 | Fact | Form ADV |
| First Form ADV filing | 2012-05-14 | Mar 25, 2024 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-30 | Oct 1, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-29 | Sep 30, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-25 | Sep 26, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-23 | Sep 24, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-21 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-22 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1 | Sep 12, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2026-03-30 | Mar 30, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2024-03-25 | Mar 25, 2024 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 30, 2026 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 25, 2024 | Fact | Form ADV |
| Business phone | Mar 25, 2024 | Fact | Form ADV | |
| Description | Sep 30, 2026 | Fact | ||
| Description | Sep 16, 2026 | Fact | ||
| Description | Sep 14, 2026 | Fact | ||
| Headquarters | Mar 25, 2024 | Fact | Form ADV | |
| Office address | Mar 25, 2024 | Fact | Form ADV | |
| Self-described type | Venture capital | Sep 30, 2026 | Fact | |
| Self-described type | Venture capital | Sep 16, 2026 | Fact | |
| Self-described type | Venture capital | Sep 14, 2026 | Fact | |
| Legal form | Corporation | Mar 25, 2024 | Fact | Form ADV |
| Portfolio page | Sep 30, 2026 | Fact | ||
| Portfolio page | Sep 16, 2026 | Fact | ||
| Portfolio page | Sep 14, 2026 | Fact | ||
| Private funds reported | 8 | Mar 30, 2026 | Fact | Form ADV |
| Private funds reported | 8 | Mar 25, 2024 | Fact | Form ADV |
| Private fund gross assets (reported) | $66.6M | Mar 30, 2026 | Fact | Form ADV |
| Private fund gross assets (reported) | $57.6M | Mar 25, 2024 | Fact | Form ADV |
| Schedule a diff | sadiff-1 | Mar 30, 2026 | Fact | Form ADV |
| Stated geography | Boston, canada, global “geography words on the home page” | Sep 30, 2026 | Fact | |
| Stated geography | Boston, canada, global “geography words on the home page” | Sep 16, 2026 | Fact | |
| Stated geography | Boston, canada, global “geography words on the home page” | Sep 14, 2026 | Fact | |
| Stated sectors | Biotech, medtech, media “sector words on the home page” | Sep 30, 2026 | Fact | |
| Stated sectors | Biotech, media “sector words on the home page” | Sep 16, 2026 | Fact | |
| Stated sectors | Biotech, media “sector words on the home page” | Sep 14, 2026 | Fact | |
| Stated stages | Series a, series b, growth “stage words on the home page” | Sep 30, 2026 | Fact | |
| Stated stages | Series b, growth “stage words on the home page” | Sep 16, 2026 | Fact | |
| Stated stages | Series b, growth “stage words on the home page” | Sep 14, 2026 | Fact | |
| Team page | Sep 30, 2026 | Fact | ||
| Team page | Sep 16, 2026 | Fact | ||
| Team page | Sep 14, 2026 | Fact | ||
| Venture funds reported | 8 | Mar 30, 2026 | Fact | Form ADV |
| Venture funds reported | 8 | Mar 25, 2024 | Fact | Form ADV |
| Website | Mar 25, 2024 | Fact | Form ADV | |
| Website resolved domain | lumiraventures.com | Sep 30, 2026 | Fact | |
| Website resolved domain | lumiraventures.com | Sep 16, 2026 | Fact | |
| Website resolved domain | lumiraventures.com | Sep 14, 2026 | Fact | |
| Site title | Sep 30, 2026 | Fact | ||
| Site title | Sep 16, 2026 | Fact | ||
| Site title | Sep 14, 2026 | Fact |
How this is scored
Scores, classification basis and filing advisersInstitutional venture firm, probableShowHide
Venture manager, reported GAV $67M across 8 vehicles
- importance
- gav: 0.25 · funds: 0.67 · people: 0.72 · investments: 0.29 · co investors: 0.31
- active deployment
- investments 12m: 0.25 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 0 · latest investment at: 2026-09-22
- emerging manager
- fund count: 8 · reported gav: $66.6M · first adv filing: 2012-05-14 · years since first filing: 14.4
Fits, record history and connections
scored matches for this investor, every identity change, every edge
Record history
- Adviser's first ADV filing2012-05-14source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.